Clinical Trial Update: Improving End of Life Care in Head and Neck Cancer

View source ↗

Summary

A Memorial Sloan Kettering trial evaluating end-of-life care for head and neck squamous cell carcinoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: The Families or Next of Kin of Patients Treated at MSKCC for Non-cutaneous Squamous Cell Carcinomas of the, Upper Aerodigestive Tract | Status: TERMINATED